Regulating Metabolism: From Obesity to CancerA better understanding of metabolism has led researchers to explore its role in diabetes, obesity, and cancer. What are the implications for clinical practice?
Should Doctors Invest in Facebook?Investors often kick themselves for not having grabbed the opportunity to invest early in Microsoft or other companies that skyrocketed. Could Facebook be the same type of opportunity?
What Would Healthcare Be Like Under 'President Romney'?The Presidential election is months away, but physicians, consumers, and politicians are speculating on changes Mitt Romney might make to our current healthcare system. Here are some possibilities.
Medscape Business of Medicine, May 2012
Medscape's Best Places to PracticeLooking for a great place to practice medicine? You've got some terrific options. We analyzed physician density, malpractice coverage, insurance competition, medical board activity, insurance mix, income taxes, and cost of living in all 50 US states and the District of Columbia and come up with a list of the best -- and the worst -- states to practice in each region.
Medscape Features Slideshows, May 2012
More Patients, More Revenue, but Less Rush. How?Doctors may think the only way to increase revenue is to add services, do more marketing, and change their practice. But there are ways to make more money by adapting what you're already doing. Here's how.
Medscape Business of Medicine, May 2012
of
Diabetes & Endocrinology News
– From Medscape Medical News, Reuters and more
Pioglitazone Once Again Linked to Bladder Cancer Risk In a nested case-control study, pioglitazone was associated with increased risk for bladder cancer among persons with type 2 diabetes, as well as doubling of risk after 2 years of treatment.
Medscape Medical News, May 31, 2012
AACEPrediction and Prevention of Type 1 DiabetesAACE 2012: Drugs aimed at halting the molecular destruction of beta cells are likely the next step in the quest to stop the progression of autoimmune type 1 diabetes.
